RBC-derived vesicles as a systemic delivery system of doxorubicin for lysosomal-mitochondrial axis-improved cancer therapy
Introduction: Chemotherapeutic drugs are the main intervention for cancer management, but many drawbacks impede their clinical applications. Nanoparticles as drug delivery systems (DDSs) offer much promise to solve these limitations. Objectives: A novel nanocarrier composed of red blood cell (RBC)-d...
Main Authors: | Shu-Hui Wu, Chia-Chu Hsieh, Szu-Chun Hsu, Ming Yao, Jong-Kai Hsiao, Shih-Wei Wang, Chih-Peng Lin, Dong-Ming Huang |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-05-01
|
Series: | Journal of Advanced Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2090123220302356 |
Similar Items
-
Potential Treatment of Lysosomal Storage Disease through Modulation of the Mitochondrial–Lysosomal Axis
by: Myeong Uk Kuk, et al.
Published: (2021-02-01) -
Mitochondrial–Lysosomal Axis in Acetaminophen Hepatotoxicity
by: Anna Moles, et al.
Published: (2018-05-01) -
Propranolol Sensitizes Vascular Sarcoma Cells to Doxorubicin by Altering Lysosomal Drug Sequestration and Drug Efflux
by: Jhuma Saha, et al.
Published: (2021-02-01) -
Lysosomal and Mitochondrial Liaisons in Niemann-Pick Disease
by: Sandra Torres, et al.
Published: (2017-11-01) -
Synergistic Effect of Mitochondrial and Lysosomal Dysfunction in Parkinson’s Disease
by: Flora Guerra, et al.
Published: (2019-05-01)